While semaglutide itself is a glucagon-like peptide-1 (GLP-1) receptor agonist designed to help control blood sugar and promote weight loss, compounded versions may not always contain the same active ingredients or meet the same rigorous safety standards as their FDA-approved counterparts
Because it can cause drowsiness, it is sometimes prescribed to help with sleep disturbances
As demonstrated in this study, short-acting GLP-1RAs, such as lixisenatide, were associated with a significantly higher risk of nausea and vomiting compared to long-acting and ultra-long-acting GLP-1RAs, such as dulaglutide and semaglutide
Because on a molecular level, you are
What is pulsatile tinnitus and is it related to IIH
These findings point to BPC-157 as a potential game-changer in treatment